Orphazyme A/S (ORPHA.CO)

DKK 1120.0

(-2.61%)

Gross Profit Summary of Orphazyme A/S

  • Orphazyme A/S's latest annual gross profit in 2023 was - DKK , up 100.0% from previous year.
  • Orphazyme A/S's latest quarterly gross profit in 2024 Q2 was - DKK , down 0.0% from previous quarter.
  • Orphazyme A/S reported a annual gross profit of -782 Thousand DKK in annual gross profit 2022, down -104.32% from previous year.
  • Orphazyme A/S reported a annual gross profit of 18.08 Million DKK in annual gross profit 2021, up 447.8% from previous year.
  • Orphazyme A/S reported a quarterly gross profit of - DKK for 2024 Q2, down 0.0% from previous quarter.
  • Orphazyme A/S reported a quarterly gross profit of - DKK for 2023 Q4, down 0.0% from previous quarter.

Annual Gross Profit Chart of Orphazyme A/S (2023 - 2015)

Historical Annual Gross Profit of Orphazyme A/S (2023 - 2015)

Year Gross Profit Gross Profit Growth
2023 - DKK 100.0%
2022 -782 Thousand DKK -104.32%
2021 18.08 Million DKK 447.8%
2020 -5.19 Million DKK -36.74%
2019 -3.8 Million DKK -178.33%
2018 -1.36 Million DKK -83.11%
2017 -746 Thousand DKK -30.42%
2016 -572 Thousand DKK 0.0%
2015 - DKK 0.0%

Peer Gross Profit Comparison of Orphazyme A/S

Name Gross Profit Gross Profit Difference
ALK-Abelló A/S 3.03 Billion DKK 100.0%
Bavarian Nordic A/S 4.52 Billion DKK 100.0%
Genmab A/S 16.24 Billion DKK 100.0%
Gubra A/S 114.93 Million DKK 100.0%
Novo Nordisk A/S 196.49 Billion DKK 100.0%
Pharma Equity Group A/S -480 Thousand DKK 100.0%
Zealand Pharma A/S 323.61 Million DKK 100.0%